Ready-made ETF portfolios built for real investor needs. Explore now →

Advertisement

ARKGvsFMEDETF Comparison

ETF 1
ARKG

ARK Genomic Revolution ETF

This fund is part of
BioTech & Genomics
-1.96%
VS
ETF 2
FMED

Fidelity Disruptive Medicine ETF

This fund is part of
Multiple Trends
-1.93%

ARK Genomic Revolution ETF (ARKG) belongs to the BioTech & Genomics segment. Fidelity Disruptive Medicine ETF (FMED) is part of the Multiple Trends segment. Both ETFs have the same top 1 sector exposures: Healthcare. ARKG is more expensive with a Total Expense Ratio (TER) of 0.75%, versus 0.5% for FMED. ARKG is up 55.33% year-to-date (YTD) with +$52M in YTD flows. FMED performs worse with 13.79% YTD performance, and -$17M in YTD flows. Run a side-by-side ETF comparison of ARKG and FMED below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.

Find out how industry players manage ETF portfolios.  Discover our library of Model portfolios

ARKG vs FMED performance and flow charts

Performance

0510%Aug 10Aug 17Aug 24Aug 31Sep 7

Cumulative Flows

-50,000,000050,000,000100,000,000Aug 10Aug 17Aug 24Aug 31Sep 7

Get all the metrics on this page, and more, through a reliable ETF data feed

Daily, global ETF data for advanced analysis or integration into apps (API), from our partner Trackinsight.

Historic performance and flows
Data as of 09/10/2026
1M3MYTD1Y3Y5Y
Perf.
ARKG
FMED
+2.26%+1.62%
+38.05%+23.52%
+55.33%+13.79%
+83.03%+24.82%
+43.84%+31.22%
-45.48%n/a
Flows
ARKG
FMED
+$26M-
+$132M-
+$52M-$17M
+$69M-$14M
-$505M-$3M
-$2.24B-
Volatility and drawdown
3M1Y3Y5Y
Volatility
ARKG
FMED
+43.14%+24.38%
+44.21%+21.02%
+43.94%+19.22%
+46.36%n/a
Max drawdown
ARKG
FMED
-13.89%-7.15%
-27.52%-17.78%
-46.41%-19.20%
-78.04%n/a
Max drawdown duration
ARKG
FMED
32d29d
126d212d
882d267d
1817dn/a
Trading data

Create an account to view trading data

Join for free
ARKG
FMED
Last sale
9/11/2026 at 1:30 PM
$45.56
Previous close
09/10/2026
$45.38
Consolidated volume
09/10/2026
Average volume
30 days
Average discount or premium
30 days
Average Bid/Ask spread
30 days
Advertisement
Main metrics
Last update 9/11/2026 at 1:30 PM
Live
Closed
ARKG
FMED
Last price
$45.56
1D performance
+0.40%
AuM$1.84 B$50.06 M
E/R0.75%0.5%
Characteristics
ARKG
FMED
Management strategyActiveActive
ProviderArk InvestmentFidelity
Benchmark--
N° of holdings3174
Asset class--
Trailing 12m distribution yield
Join
Join
Inception dateApril 2, 2019June 12, 2023
ESGNoNo
Advertisement
Exposure

Countries

ARKG
USA
88.43%
Other
11.57%
FMED
USA
83.4%
Other
16.6%

Sectors

ARKG
Healthcare
97.99%
Other
2.01%
FMED
Healthcare
100%
Other
0%
Advertisement

Diversification

ARKG

Total weight of top 15 holdings out of 15

75.55%
FMED

Total weight of top 15 holdings out of 15

43.09%

Top 15 holdings

Data as of July 31, 2026
ARKG
10X Genomics, Inc.
9.41%
Twist Bioscience Corp.
7.74%
Tempus AI, Inc.
6.57%
CRISPR Therapeutics AG
6.30%
Personalis, Inc.
5.48%
Absci Corp.
5.15%
Guardant Health, Inc.
4.75%
Illumina, Inc.
4.75%
Eli Lilly & Co.
4.69%
CareDx, Inc.
4.31%
Natera, Inc.
4.14%
Beam Therapeutics, Inc.
3.78%
Compass Pathways Plc
3.26%
Recursion Pharmaceuticals, Inc.
2.63%
Adaptive Biotechnologies Corp.
2.58%
FMED
10X Genomics, Inc.
4.48%
Thermo Fisher Scientific, Inc.
3.98%
Danaher Corp.
3.86%
Lifestance Health Group, Inc.
3.15%
Alnylam Pharmaceuticals, Inc.
3.10%
argenx SE
2.99%
Cogent Biosciences, Inc.
2.98%
Revolution Medicines, Inc.
2.85%
Illumina, Inc.
2.62%
Intuitive Surgical, Inc.
2.34%
Kymera Therapeutics, Inc.
2.29%
UnitedHealth Group, Inc.
2.24%
Ascendis Pharma A/S
2.12%
Kiniksa Pharmaceuticals International Plc
2.06%
UCB SA
2.03%
Frequently asked questions about ARKG and FMED

How have the ARKG and FMED ETFs performed in 2026?

As of September 10, 2026, ARKG is up 55.33% year-to-date (YTD), while FMED has returned 13.79%. That puts ARKG better performer ahead so far this year.

Which ETF is attracting more investor money: ARKG or FMED?

Year-to-date, the ARKG ETF saw +$52M in flows, compared to -$17M for FMED.

Which ETF is more volatile: ARKG or FMED?

Over the past year, ARKG had a volatility of 44.21%, while FMED experienced 21.02%.

Which ETF is bigger: ARKG or FMED?

As of September 10, 2026, ARKG holds $1.84 B in assets under management (AUM), while FMED manages $50.06 M.

What sectors do the ARKG and FMED ETFs invest in?

ARKG leans toward sectors like Healthcare. Meanwhile, FMED focuses on Healthcare.

What are the top holdings of the ARKG ETF and FMED ETF?

ARKG top holdings include 10X Genomics, Inc., Twist Bioscience Corp. and Tempus AI, Inc.. FMED holds in its top three: 10X Genomics, Inc., Thermo Fisher Scientific, Inc. and Danaher Corp..

Which ETF is more diversified: ARKG or FMED?

ARKG holds 31 securities with 75.55% of its assets in the top 15. FMED has 74 securities and a top 15 weight of 43.09%.

Advertisement
Latest news about ARKG & FMED
Advertisement
Advertisement
ETF INVESTOR RESOURCES

Expert-Built ETF Portfolios, All in One Place

Don’t start from scratch. Discover ready-made ETF portfolios built by professionals to match different goals, timelines, and market views. Use them as inspiration or as a starting point for your own allocation.

Portfolio Builder